What would it take to get peptides on the shelf?
- FDA panel backs six of seven peptides for compounding pharmacy production.
- Peptides like BPC-157 lack large human safety trials.
- Legal sales still need formal FDA action; could take months.
An FDA advisory panel has recommended approving six of seven popular peptide therapies, including BPC-157, TB-500 and MOTS-c, for production by compounding pharmacies, marking the first serious regulatory attention paid to a booming but currently illegal wellness market. The peptides are widely used off-label for injury recovery, muscle…